
Neuronetics is a diagnostics & research business based in the US. Neuronetics shares (STIM) are listed on the NASDAQ and all prices are listed in US Dollars. Neuronetics employs 194 staff and has a trailing 12-month revenue of around $65.2 million.
How to buy Neuronetics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – STIM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Neuronetics stock price (NASDAQ: STIM)
Use our graph to track the performance of STIM stocks over time.Neuronetics shares at a glance
Latest market close | $2.93 |
---|---|
52-week range | $1.98 - $6.95 |
50-day moving average | $5.12 |
200-day moving average | $4.42 |
Wall St. target price | $8.67 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.15 |
Buy Neuronetics stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Neuronetics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Neuronetics price performance over time
Historical closes compared with the close of $2.93 from 2023-03-23
1 week (2023-03-17) | 3.53% |
---|---|
1 month (2023-02-20) | N/A |
3 months (2022-12-23) | -50.92% |
6 months (2022-09-22) | 10.57% |
1 year (2022-03-22) | -11.75% |
---|---|
2 years (2021-03-24) | -76.73% |
3 years (2020-03-24) | 100.68% |
5 years (2018-03-20) | N/A |
Neuronetics financials
Revenue TTM | $65.2 million |
---|---|
Gross profit TTM | $49.7 million |
Return on assets TTM | -16.71% |
Return on equity TTM | -52.25% |
Profit margin | -56.99% |
Book value | $2.09 |
Market capitalisation | $83.1 million |
TTM: trailing 12 months
Neuronetics share dividends
We're not expecting Neuronetics to pay a dividend over the next 12 months.
Neuronetics share price volatility
Over the last 12 months, Neuronetics's shares have ranged in value from as little as $1.98 up to $6.952. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neuronetics's is 2.0287. This would suggest that Neuronetics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Neuronetics overview
Neuronetics, Inc. , a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Neuronetics in the news
NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA
NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA
Neuronetics, Inc. (NASDAQ:STIM) Q4 2022 Earnings Call Transcript
Frequently asked questions
What percentage of Neuronetics is owned by insiders or institutions?Currently 5.025% of Neuronetics shares are held by insiders and 69.157% by institutions. How many people work for Neuronetics?
Latest data suggests 194 work at Neuronetics. When does the fiscal year end for Neuronetics?
Neuronetics's fiscal year ends in December. Where is Neuronetics based?
Neuronetics's address is: 3222 Phoenixville Pike, Malvern, PA, United States, 19355 What is Neuronetics's ISIN number?
Neuronetics's international securities identification number is: US64131A1051 What is Neuronetics's CUSIP number?
Neuronetics's Committee on Uniform Securities Identification Procedures number is: 64131A105
More guides on Finder
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert